In celiac disease, zonulin is released from enterocytes after exposure to gliadin, activates protease-activated receptor 2 (PAR2) in a paracrine manner, and perturbs the actin cytoskeleton and cell-cell junctions in the gut epithelium (13–16). Here, F2RL1 is linked to celiac disease.